Notch vs Midpoint Suprascapular Nerve PRF for Chronic Shoulder Pain
RecruitingNot applicableNCT07502209
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to compare the effects of pulsed radiofrequency (PRF) treatment of the suprascapular nerve using suprascapular notch and midpoint approaches on pain, shoulder function, and muscle strength in patients with chronic shoulder pain due to rotator cuff tendinopathy. Patients will be randomly assigned to one of the two intervention groups. Clinical evaluations will include pain assessment using the Numeric Rating Scale (NRS), functional assessment using the Shoulder Pain and Disability Index (SPADI), and quality of life assessment using the Short Form-36 (SF-36). In addition, shoulder range of motion will be measured goniometrically, muscle thickness of the supraspinatus and infraspinatus will be evaluated by ultrasonography, and shoulder muscle strength will be assessed using an isokinetic dynamometer. Assessments will be performed at baseline, 24 hours, 1 month, and 3 months after the intervention. The results of this study are expected to provide evidence regarding the optimal approach for PRF treatment of the suprascapular nerve in patients with chronic shoulder pain.
Study details
- Official title
- Comparison of Suprascapular Notch and Midpoint Approaches in Pulsed Radiofrequency Treatment of the Suprascapular Nerve on Pain and Function in Patients With Chronic Shoulder Pain
- Conditions
- Chronic Shoulder Pain
- Rotator Cuff Tendinopathy
- Interventions
- Procedure: PRF of the Suprascapular Nerve (Notch Approach)
- Procedure: PRF of the Suprascapular Nerve (Midpoint Approach)
- Sponsor
- Ankara City Hospital Bilkent
- Start date
- 2026-05-07
- Primary completion
- 2027-06-30
- Sex
- All
- Age range
- from 40 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients aged between 40 and 80 years * Patients with chronic shoulder pain lasting longer than 3 months * Patients diagnosed with rotator cuff-related shoulder pain * Patients who show at least 50% pain reduction after diagnostic suprascapular nerve block * Patients who provide written informed consent Exclusion Criteria: * Adhesive capsulitis * Previous shoulder surgery * Full-thickness rotator cuff tear * Neurological disorders affecting the shoulder * Pacemaker * Coagulopathy or anticoagulant therapy contraindicating intervention * Infection at the injection site * Severe systemic disease * Pregnancy * Inability to comply with study protocol
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07502209